BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24727060)

  • 1. A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy.
    Miyabe H; Hyodo M; Nakamura T; Sato Y; Hayakawa Y; Harashima H
    J Control Release; 2014 Jun; 184():20-7. PubMed ID: 24727060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma.
    Nakamura T; Miyabe H; Hyodo M; Sato Y; Hayakawa Y; Harashima H
    J Control Release; 2015 Oct; 216():149-57. PubMed ID: 26282097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response.
    Parvatiyar K; Zhang Z; Teles RM; Ouyang S; Jiang Y; Iyer SS; Zaver SA; Schenk M; Zeng S; Zhong W; Liu ZJ; Modlin RL; Liu YJ; Cheng G
    Nat Immunol; 2012 Dec; 13(12):1155-61. PubMed ID: 23142775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STING is a direct innate immune sensor of cyclic di-GMP.
    Burdette DL; Monroe KM; Sotelo-Troha K; Iwig JS; Eckert B; Hyodo M; Hayakawa Y; Vance RE
    Nature; 2011 Sep; 478(7370):515-8. PubMed ID: 21947006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a negative feedback loop between cyclic di-GMP-induced levels of IFI16 and p202 cytosolic DNA sensors and STING.
    Panchanathan R; Liu H; Xin D; Choubey D
    Innate Immun; 2014 Oct; 20(7):751-9. PubMed ID: 24131791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.
    Shariat S; Badiee A; Jalali SA; Mansourian M; Yazdani M; Mortazavi SA; Jaafari MR
    Cancer Lett; 2014 Dec; 355(1):54-60. PubMed ID: 25224570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP.
    McWhirter SM; Barbalat R; Monroe KM; Fontana MF; Hyodo M; Joncker NT; Ishii KJ; Akira S; Colonna M; Chen ZJ; Fitzgerald KA; Hayakawa Y; Vance RE
    J Exp Med; 2009 Aug; 206(9):1899-911. PubMed ID: 19652017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens.
    Alyaqoub FS; Aldhamen YA; Koestler BJ; Bruger EL; Seregin SS; Pereira-Hicks C; Godbehere S; Waters CM; Amalfitano A
    J Immunol; 2016 Feb; 196(4):1741-52. PubMed ID: 26792800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of a Drug Delivery System for Cancer Immunotherapy].
    Nakamura T
    Yakugaku Zasshi; 2016; 136(11):1477-1484. PubMed ID: 27803478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-γ gene lipoplex for efficient cancer immunotherapy.
    Yuba E; Kanda Y; Yoshizaki Y; Teranishi R; Harada A; Sugiura K; Izawa T; Yamate J; Sakaguchi N; Koiwai K; Kono K
    Biomaterials; 2015 Oct; 67():214-24. PubMed ID: 26222284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
    Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
    Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
    Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.
    Chandra D; Quispe-Tintaya W; Jahangir A; Asafu-Adjei D; Ramos I; Sintim HO; Zhou J; Hayakawa Y; Karaolis DK; Gravekamp C
    Cancer Immunol Res; 2014 Sep; 2(9):901-10. PubMed ID: 24913717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-di-GMP Induces COX-2 Expression in Macrophages in a STING-Independent Manner.
    Wang M; Chaudhuri R; Ong WWS; Sintim HO
    ACS Chem Biol; 2021 Sep; 16(9):1663-1670. PubMed ID: 34478263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice.
    Wang Z; Celis E
    Cancer Immunol Immunother; 2015 Aug; 64(8):1057-66. PubMed ID: 25986168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel c-di-GMP recognition modes of the mouse innate immune adaptor protein STING.
    Chin KH; Tu ZL; Su YC; Yu YJ; Chen HC; Lo YC; Chen CP; Barber GN; Chuah ML; Liang ZX; Chou SH
    Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):352-66. PubMed ID: 23519410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
    Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
    FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice.
    Madhun AS; Haaheim LR; Nøstbakken JK; Ebensen T; Chichester J; Yusibov V; Guzman CA; Cox RJ
    Vaccine; 2011 Jul; 29(31):4973-82. PubMed ID: 21600260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Th1/Th2 Bias of STING Agonists Coated on Microneedles for Possible Use in Skin Allergen Immunotherapy.
    Shakya AK; Lee CH; Uddin MJ; Gill HS
    Mol Pharm; 2018 Nov; 15(11):5437-5443. PubMed ID: 30299105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo.
    Sprott GD; Dicaire CJ; Gurnani K; Sad S; Krishnan L
    Infect Immun; 2004 Sep; 72(9):5235-46. PubMed ID: 15322018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.